Cetuximab versus bevacizumab maintenance following prior 8-cycle modified FOLFOXIRI plus cetuximab in Asian postmenopausal women with treatment-naive KRAS and BRAF wild-type metastatic colorectal cancer

OBJECTIVE: To assess the efficacy and safety of cetuximab (CE) versus bevacizumab (BE) maintenance treatment after prior 8-cycle modified 5-fluorouracil, folinate, oxaliplatin, and irinotecan (FOLFOXIRI) plus CE induction therapy in treatment-naive KRAS and BRAF wild-type (wt) metastatic colorectal...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Int Med Res
Autores principales: Chen, Baomin, Zheng, Donghua, Yu, Weiguang, Huang, Cuiping, Ye, Junxing, Han, Guowei, Zhuang, Jintao
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2020
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7545770/
https://ncbi.nlm.nih.gov/pubmed/32993393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060520930440
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares